Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

SPY
Federal Reserve Board Seeks Public Comment On Proposals For Stablecoin Rules Under GENIUS Act, Requiring Full Reserve Backing And Capital Standards For Supervised Issuers

Federal Reserve Board Seeks Public Comment On Proposals For Stablecoin Rules Under GENIUS Act, Requiring Full Reserve Backing And Capital Standards Fo...

MRK
FDA Approves Merck's Belzutifan With Lenvatinib For Advanced Kidney Cancer With Clear Cell Component

FDA Approves Merck's Belzutifan With Lenvatinib For Advanced Kidney Cancer With Clear Cell Component...

BA
'India’s Akasa in Talks With Boeing to Order 200 737 Max Aircraft' - Bloomberg

'India’s Akasa in Talks With Boeing to Order 200 737 Max Aircraft' - Bloomberg...

JPM
Here’s How Much You Would Have Made Owning JPMorgan Chase Stock In The Last 20 Years

Here’s How Much You Would Have Made Owning JPMorgan Chase Stock In The Last 20 Years...

MSFT
Here's How Much $1000 Invested In Microsoft 20 Years Ago Would Be Worth Today

Here's How Much $1000 Invested In Microsoft 20 Years Ago Would Be Worth Today...

ACTAVIS
FDA Approves Unknown Drug — ACTAVIS LABS FL

FDA has approved a generic drug under Application #ANDA211255 manufactured by ACTAVIS LABS FL, removing any potential generic competition for the subj...

NEPHRON
FDA Approves Unknown Drug — NEPHRON

FDA has granted approval to NEPHRON for the brand name drug referenced in ANDA215268, a regulatory milestone that solidifies the company's position in...

FDA
Federal Court Stops Warehouse Distribution Over insanitary Conditions

A federal court order on Sept. 21, 2026, halted Gold Star Distribution from selling FDA-regulated products until operations meet legal standards....

NutriBand
Nutriband Confirms Warrants Expiring Sept 30

Nutriband confirmed warrants will expire on September 30 and will not be repriced, removing roughly $5.86M in potential proceeds if not exercised....

Vertical
Vertical Data Inc. amends bylaws

Vertical Data Inc. filed an amendment to its bylaws. The prior text was truncated; the specific changes were not detailed....

Enhanced
Director pay policy announced

The company released details for a non-employee director compensation program, setting annual cash and equity grants to remain competitive on the NYSE...

OPEN
OpenText Prices $1B Senior Notes Offering

OpenText priced a $1B offering of senior secured notes for redemption of 2027 Notes and a tender offer for 2028 Notes, closing October 1, 2026....

Xenetic
Xenetic Biosciences releases investor presentation with a proposed transaction

Xenetic Biosciences has filed an exhibit containing a proposed transaction discussion and forward-looking statements, with both companies targeting a ...

CENTERSPACE
Centerspace Merger Terms Modified

Centerspace (CSU) confirmed it will merge into Independence Realty Trust (INDY) following a change to the merger structure, specifically affecting the...

KLX
KLX Energy adopts Stockholder Rights Plan

KLX Energy Services Holdings, Inc. adopted a Stockholder Protection Rights Agreement on September 23, 2026, granting rights to stockholders upon poten...

Greenland
Greenland Mines Ltd files amended charter documents

Greenland Mines Ltd filed a pre-funded warrant as part of an EX-4.1 exhibit, dated June 3, 2025. This SEC filing indicates the company's progress on u...

BIO-TECHNE
Bio-Techne shareholders approve acquisition by Merck KGaA

Bio-Techne shareholders approved the acquisition by Merck KGaA, which is expected to close by late 2026 or early 2027, subject to regulatory condition...

STONERIDGE
Stoneridge appoints Uwe Brandenburg as VP of Engineering

Stoneridge Inc. revealed the appointment of Uwe Brandenburg as Global Vice President Engineering & Innovation, effective April 1, 2027. This leadershi...

IQVIA
IQVIA launches 6.375% senior notes due 2034

IQVIA Holdings Inc. filed an indenture for the issuance of 6.375% senior notes due 2034, representing a debt financing activity that impacts the compa...

Decoy
Decoy Therapeutics Issues 2.37M Warrants to Armistice Capital

Decoy Therapeutics Inc. issued 2.37 million warrant shares to the Holder Armistice Capital as part of an inducement, with a business development miles...